Fiducial Markers Market Analysis 2026

What is the key factor hampering the growth of the Fiducial Markers Market?

Increased use of radiotherapy in cancer treatment

Radiotherapy is an effective treatment modality for several types of cancer. Radiotherapy involves the process of delivering targeted doses of radiations to the cancerous cells thereby reducing or minimizing damage to healthy tissues in the vicinity. This is where, fiducial markers play a vital role in achieving the precision by providing exact alignment and localization of the tumour and its surrounding structures. Moreover, fiducial markers are placed within or near the tumour site to serve as the reference points during the procedure of radiotherapy.

Thus, fiducial markers allow for accurate and precise localization of the tumour and its accurate position within the body. Also, by tracking the movement of fiducial markers, radiation therapy systems can accordingly adjust the radiation beam to precisely target the tumour. Apart from this, the usage of fiducial markers in radiotherapy sessions aids in improving the outcomes of treatment by increasing treatment accuracy. In addition to this, advanced radiotherapy techniques such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT) are increasingly used for cancer treatment.

Thus, overall, the increase in usage of radiotherapy in treating cancer has generated significant demand for fiducial markers. Therefore, as long as radiotherapy techniques continue to enhance and advance and the prevalence of cancer and cancer-related diseases grows, the global fiducial marker market is likely to experience a consistent growth in the coming years.

Restraining Factor for Fiducial Markers Market

Shortage of skilled professionals

With respect to lack of skilled professionals, the proper implantation and use of fiducial marker requires specialized expertise and training. Skilled professionals such as radiation oncologists, surgeons, and interventional radiologists, all of them needs to be proficient in marker placement techniques and familiar with the particular procedures involving fiducial markers. Thus, the scarcity and trained and skilled professionals is likely to restrain the growth and limit the broader adoption of fiducial markers. 

In regards with the high costs associated with fiducial markers, the fiducial markers made of specialized materials or having advanced imaging compatibility, can be highly expensive to procure. Thus, owing to the costs for procuring these markers, particularly in huge quantities can prove to be a financial burden for several healthcare facilities and can limit their adoption. Therefore, the above factors are likely to restrain the growth of the market.

Impact of the COVID-19 pandemic on the Fiducial Markers Market:

The COVID-19 pandemic moderately affected the global fiducial markers market. Several procedures including radiation therapy and imaging were often postponed or delayed to prioritize COVID-19 patients. This led to decline in number of medical procedures requiring fiducial markers. Adding to it, restrictions for non-essential healthcare visits and fear of exposure to virus reduced the number of patients visiting hospitals, thereby, affecting the market growth.

While, the supply chain of fiducial markers also faced several disruptions due to shutdown of manufacturing facilities, and insufficient raw materials. Therefore, COVID-19 moderately affected the global fiducial markers market growth.

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Fiducial Markers Market is witnessing significant growth in the near future.

In 2023, the Polymer-Based Marker segment accounted for noticeable share of global Fiducial Markers Market and is projected to experience significant growth in the near future.

The Prostate Cancer segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Eckert & Ziegler BEBIG, IBA Dosimetry and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)